coldn brought this up on the rvx board...

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

fuzzyjr

Rank: Vice President [?]

Points: 5268 [?]

Votes: 36 Score: 3.1 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

coldn brought this up on the rvx board...

posted on May 13, 2019 01:33PM

"funds generated by Zenith belong to Zenith Capital Corp. (ZCC). There is no guarantee that that money will be passed on to the share holders."

Any thoughts on what the possibilitys of this happening might be?

glta

2 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply